glp 1 roche obesity drug shows 22.5% weight loss as it seeks to catch up with Lilly, Novo Roche's GLP1/GIP drug sees 22.5%

Oral administration of Spirulina was demonstrated to decrease blood pressure and lipid concentration, particularly low density lipoprotein cholesterol (LDL-C) and triacylglycerols

Considering dose splitting Some practitioners and patients have explored splitting the weekly dose into two smaller injections given 3 to 4 days apart

What most articles get wrong about "equivalent doses" Search "Wegovy to Zepbound conversion" and you'll find tables claiming that Wegovy 1 mg "equals" Zepbound 5 mg, or that Wegovy 2.4 mg "equals" Zepbound 10 mg

Zhang, G., et al

If your liver can't package and export fat efficiently, weight loss stalls even when you're eating below maintenance